Auris Medical Holding (EARS) Posts FY16 Loss of $0.89/Share, Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Auris Medical Holding AG (EARS) PT Lowered to $4 at Needham & Company
March 14, 2017 2:14 PM EDTNeedham & Company lowered its price target on Auris Medical Holding AG (NASDAQ: EARS) to $4.00 (from $5.00) while maintaining a Buy rating. EARS reported a 4Q16 loss of CHF 5.6MM, lower than estimates for a loss of CHF 9.4MM. EARS ended 2016 with a cash... More
